PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · IEX Real-Time Price · USD
32.63
-0.18 (-0.55%)
At close: Jul 19, 2024, 4:00 PM
32.75
+0.12 (0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
PTC Therapeutics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for PTC Therapeutics stock have an average target of 35.93, with a low estimate of 17 and a high estimate of 62. The average target predicts an increase of 10.11% from the current stock price of 32.63.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for PTCT stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 6 | 5 | 6 | 6 | 6 | 6 |
| Sell | 3 | 3 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 3 | 3 | 3 |
| Total | 14 | 14 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $30 → $32 | Hold | Maintains | $30 → $32 | -1.93% | Jul 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $52 → $62 | Buy | Maintains | $52 → $62 | +90.01% | Jul 1, 2024 |
| B of A Securities | B of A Securities | Sell Maintains $25 → $32 | Sell | Maintains | $25 → $32 | -1.93% | Jun 21, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $53 | Buy | Maintains | $53 | +62.43% | Jun 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $18 → $32 | Strong Sell | Maintains | $18 → $32 | -1.93% | May 28, 2024 |
Financial Forecast
Revenue This Year
757.63M
from 937.82M
Decreased by -19.21%
Revenue Next Year
822.23M
from 757.63M
Increased by 8.53%
EPS This Year
-5.11
from -8.37
EPS Next Year
-2.91
from -5.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 911.6M | 1.1B | 1.3B | 1.6B | 1.9B |
| Avg | 757.6M | 822.2M | 915.8M | 1.1B | 1.3B |
| Low | 609.6M | 519.4M | 584.9M | 838.7M | 987.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.8% | 41.4% | 60.9% | 73.3% | 73.9% |
| Avg | -19.2% | 8.5% | 11.4% | 16.4% | 23.4% |
| Low | -35.0% | -31.4% | -28.9% | -8.4% | -7.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.22 | 2.68 | 3.33 | -1.14 | 2.30 |
| Avg | -5.11 | -2.91 | -1.18 | -1.11 | 2.23 |
| Low | -6.16 | -6.21 | -7.45 | -1.07 | 2.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.